If you suffer from chronic pain and think you have to travel far from home for state-of-the-art technology and innovative ...
Recent advances in headache and sensory neuroscience have revealed that aura and sensory disturbances are complex phenomena present across a spectrum of ...
Mesoblast shares (ASX: MSB) ended the day flat at A$2.54, despite having received critical feedback from the U.S. Food and Drug Administration that could accelerate the pathway to market for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback